Total Payments
$14,179
2024 Payments
$961.44
Companies
49
Transactions
464
Medicare Patients
2,610
Medicare Billing
$439,714
Payment Breakdown by Category
Food & Beverage$8,697 (61.3%)
Consulting$2,678 (18.9%)
Travel$893.37 (6.3%)
Other$822.78 (5.8%)
Gifts$772.34 (5.4%)
Education$316.12 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,697 | 447 | 61.3% |
| Consulting Fee | $2,678 | 4 | 18.9% |
| Travel and Lodging | $893.37 | 5 | 6.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $822.78 | 2 | 5.8% |
| Gift | $772.34 | 1 | 5.4% |
| Education | $316.12 | 5 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $1,811 | 3 | $0 (2018) |
| Astellas Pharma US Inc | $1,311 | 64 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $1,271 | 21 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,186 | 12 | $0 (2023) |
| Janssen Biotech, Inc. | $1,129 | 75 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $1,001 | 42 | $0 (2024) |
| ABBVIE INC. | $783.29 | 56 | $0 (2024) |
| NxThera, Inc. | $772.34 | 1 | $0 (2017) |
| PFIZER INC. | $445.96 | 42 | $0 (2023) |
| Lumenis, Inc | $422.78 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $961.44 | 37 | ABBVIE INC. ($148.70) |
| 2023 | $2,159 | 39 | Bayer Healthcare Pharmaceuticals Inc. ($988.35) |
| 2022 | $1,231 | 61 | Dendreon Pharmaceuticals LLC ($368.01) |
| 2021 | $1,218 | 58 | Dendreon Pharmaceuticals LLC ($299.32) |
| 2020 | $1,608 | 52 | Boston Scientific Corporation ($982.45) |
| 2019 | $1,513 | 74 | Astellas Pharma US Inc ($397.80) |
| 2018 | $2,990 | 94 | Janssen Scientific Affairs, LLC ($1,811) |
| 2017 | $2,499 | 49 | NxThera, Inc. ($772.34) |
All Payment Transactions
464 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Oncology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $24.64 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: Oncology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $25.10 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $124.20 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: UROLOGY | ||||||
| 08/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Oncology | ||||||
| 08/15/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: ONCOLOGY | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: UROLOGY | ||||||
| 07/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Oncology | ||||||
| 06/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/26/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: HORMONE THERAPY | ||||||
| 06/25/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Oncology | ||||||
| 06/06/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/21/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 591 | 1,234 | $305,689 | $94,555 |
| 2022 | 15 | 669 | 1,515 | $353,482 | $111,131 |
| 2021 | 15 | 698 | 1,410 | $334,120 | $110,132 |
| 2020 | 13 | 652 | 1,501 | $371,846 | $123,896 |
Total Patients
2,610
Total Services
5,660
Medicare Billing
$439,714
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 26 | 200 | $127,832 | $25,888 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 174 | 365 | $49,275 | $24,292 | 49.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 43 | 58 | $22,620 | $11,039 | 48.8% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 35 | 137 | $22,605 | $7,574 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 69 | $11,523 | $6,293 | 54.6% |
| 52281 | Dilation of urethra using an endoscope | Office | 2023 | 13 | 13 | $7,410 | $3,439 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $7,660 | $3,320 | 43.3% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 12 | 14 | $10,136 | $2,751 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $7,710 | $2,454 | 31.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 28 | 80 | $3,840 | $2,270 | 59.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $4,290 | $1,828 | 42.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 12 | 14 | $5,852 | $1,629 | 27.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 89 | 131 | $15,720 | $1,068 | 6.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 12 | 14 | $8,876 | $681.10 | 7.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 15 | 68 | $340.00 | $28.36 | 8.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 35 | 239 | $147,112 | $31,506 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 197 | 420 | $56,700 | $27,849 | 49.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 66 | 78 | $30,420 | $14,622 | 48.1% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2022 | 46 | 191 | $31,515 | $10,819 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 54 | $9,120 | $4,740 | 52.0% |
| 52281 | Dilation of urethra using an endoscope | Office | 2022 | 12 | 14 | $7,980 | $3,976 | 49.8% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 19 | 21 | $15,204 | $3,743 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $9,920 | $3,654 | 36.8% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 36 | 119 | $5,712 | $3,366 | 58.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 35 | 35 | $8,995 | $2,126 | 23.6% |
About Dr. Daniel Lama, MD
Dr. Daniel Lama, MD is a Urology healthcare provider based in San Bernardino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972517928.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Lama, MD has received a total of $14,179 in payments from pharmaceutical and medical device companies, with $961.44 received in 2024. These payments were reported across 464 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($8,697).
As a Medicare-enrolled provider, Lama has provided services to 2,610 Medicare beneficiaries, totaling 5,660 services with total Medicare billing of $439,714. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location San Bernardino, CA
- Active Since 07/27/2006
- Last Updated 05/02/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1972517928
Products in Payments
- Erleada (Drug) $2,342
- Nubeqa (Drug) $1,058
- PROVENGE (Drug) $1,033
- SPACEOAR (Device) $917.56
- XTANDI (Drug) $809.52
- Rezum (Device) $772.34
- LUPRON DEPOT (Drug) $522.24
- JEVTANA (Drug) $400.00
- LYNPARZA (Drug) $396.42
- ELIGARD (Drug) $375.62
- ERLEADA (Drug) $375.20
- Xtandi (Drug) $371.59
- AQUABEAM ROBOTIC SYSTEM (Device) $309.94
- NEOX (Medical Supply) $254.04
- ZYTIGA (Drug) $222.12
- FIRMAGON (Drug) $180.36
- KEYTRUDA (Biological) $164.04
- TOVIAZ (Drug) $161.28
- ADSTILADRIN (Biological) $142.07
- ORGOVYX (Drug) $135.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in San Bernardino
Avinash Chenam, M.d, M.D
Urology — Payments: $72,529
Urology $72,529
Dr. Steve Dong, M.d, M.D
Urology — Payments: $24,804
Urology $24,804
Franklin Chu, Md, MD
Urology — Payments: $22,760
Urology $22,760
Sun Kim, Md, MD
Urology — Payments: $21,552
Urology $21,552
David Koslov, Md, MD
Urology — Payments: $4,359
Urology $4,359
Vincent Wong
Urology — Payments: $2,408
Urology $2,408